立体定向体部放射治疗与射频消融治疗肝细胞癌：比较不可比的数据。 - Suppr | 超能文献

Stereotactic body radiation therapy vs. radiofrequency ablation in HCC: comparing noncomparable data.

作者信息

Guiu Boris

机构信息

Department of Radiology, St-Eloi University Hospital, 34980 Montpellier, France.

出版信息

J Hepatol. 2020 Sep;73(3):727-728. doi: 10.1016/j.jhep.2020.04.017. Epub 2020 May 15.

DOI:10.1016/j.jhep.2020.04.017

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Stereotactic body radiation therapy vs. radiofrequency ablation in HCC: comparing noncomparable data.立体定向体部放射治疗与射频消融治疗肝细胞癌：比较不可比的数据。

J Hepatol. 2020 Sep;73(3):727-728. doi: 10.1016/j.jhep.2020.04.017. Epub 2020 May 15.

2

Stereotactic body radiation therapy vs. radiofrequency ablation for HCC: More questions than answers.立体定向体部放射治疗与射频消融治疗肝癌：问题多于答案。

J Hepatol. 2020 Oct;73(4):972-973. doi: 10.1016/j.jhep.2020.05.018. Epub 2020 Aug 6.

3

Reply to: "Stereotactic body radiation therapy vs. radiofrequency ablation for HCC: More questions than answers".回复：“立体定向体部放射治疗与射频消融治疗肝癌：问题多于答案”

J Hepatol. 2020 Oct;73(4):973-974. doi: 10.1016/j.jhep.2020.05.031. Epub 2020 Jul 6.

4

Can sorafenib use influence outcome when comparing stereotactic body radiation therapy with radiofrequency ablation in patients with hepatocellular carcinoma?在肝细胞癌患者中，比较立体定向体部放射治疗与射频消融时，索拉非尼的使用会影响结果吗？

J Hepatol. 2020 Aug;73(2):467-468. doi: 10.1016/j.jhep.2020.03.016. Epub 2020 May 11.

5

Reply to: "Can sorafenib use influence outcome when comparing stereotactic body radiation therapy with radiofrequency ablation in patients with hepatocellular carcinoma?".回复：“在肝细胞癌患者中，比较立体定向体部放疗与射频消融时，索拉非尼的使用会影响结果吗？”

J Hepatol. 2020 Aug;73(2):468-469. doi: 10.1016/j.jhep.2020.04.016. Epub 2020 May 25.

6

Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma: Does Radiation Dose Make a Difference?射频消融与立体定向体部放疗治疗局限性肝细胞癌：辐射剂量有影响吗？

J Clin Oncol. 2018 Aug 20;36(24):2566-2567. doi: 10.1200/JCO.2018.78.6012. Epub 2018 Jun 26.

7

In reply to Huo et al.: Treating small hepatocellular carcinoma: Stereotactic body radiation therapy versus radiofrequency ablation.回复霍等人：小肝细胞癌的治疗：立体定向体部放射治疗与射频消融术对比

J Gastroenterol Hepatol. 2020 Dec;35(12):2293. doi: 10.1111/jgh.15250. Epub 2020 Sep 21.

8

Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: Caution When Interpreting Observational Data.射频消融术与立体定向体部放射治疗肝细胞癌：解读观察性数据时需谨慎

J Clin Oncol. 2018 Aug 20;36(24):2558. doi: 10.1200/JCO.2018.78.0122. Epub 2018 Jun 26.

9

Are Head-to-Head Comparisons Between Radiofrequency Ablation and Stereotactic Body Radiotherapy Really Necessary for Localized Hepatocellular Carcinoma?对于局限性肝细胞癌，射频消融与立体定向体部放疗之间真的需要进行直接比较吗？

J Clin Oncol. 2018 Aug 20;36(24):2563-2564. doi: 10.1200/JCO.2018.78.2805. Epub 2018 Jun 26.

10

Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: No Way Out Without a Randomized Trial?肝细胞癌的射频消融与立体定向体部放疗：没有随机试验就无路可走？

J Clin Oncol. 2018 Aug 20;36(24):2558-2559. doi: 10.1200/JCO.2018.78.1005. Epub 2018 Jun 26.

引用本文的文献

1

Single-Cell Sequencing Identifies the Heterogeneity of CD8+ T Cells and Novel Biomarker Genes in Hepatocellular Carcinoma.单细胞测序鉴定肝癌 CD8+T 细胞异质性和新型生物标志物基因。

J Healthc Eng. 2022 Apr 12;2022:8256314. doi: 10.1155/2022/8256314. eCollection 2022.